ArticleNeurologia medico-chirurgica2025
Prediction of Seizure Outcome Using Combinations of Four Noninvasive Presurgical Modalities in Magnetic Resonance Imaging-negative Focal Intractable Epilepsy.
Article in Neurologia medico-chirurgica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Risk factors for extra-axial hemorrhage during invasive monitoring using subdural electrodes.Neurosurgical review · 2026Article
- Multimodal quantitative analysis guides precise preoperative localization of epilepsy.Journal of neurology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In focal epilepsy cases, precise identification and resection of the epileptogenic zone increase the likelihood of achieving a seizure-free outcome. Nevertheless, localizing the source of epilepsy in magnetic resonance imaging-negative epilepsy cases presents significant challenges for clinicians. In this study, we evaluated the diagnostic efficacy and impact on the seizure outcome by using 4 noninvasive modalities, including scalp video electroencephalography, magnetoencephalography, fluorodeoxyglucose-positron emission tomography, and iomazenil single-photon emission computed tomography, in a cohort of patients with magnetic resonance imaging-negative focal epilepsy who underwent resective surgery. The concordance status of each modality was assessed relative to the lobar resection area, and surgical outcome was assessed by Engel Classification at least 1 year after surgery. Comparison and diagnostic analyses were calculated for each individual and all possible combinations of scalp video electroencephalography, magnetoencephalography, fluorodeoxyglucose-positron emission tomography, and single-photon emission computed tomography with respect to Engel class I outcome. Eighteen patients (66.6%, 18/27) had Engel class I outcomes. Patients with at least 2 concordant modalities were associated with Engel class I outcome (p = 0.0262). For individual modality, fluorodeoxyglucose-positron emission tomography achieved the highest yield of sensitivity (72.2%) compared to scalp video electroencephalography, magnetoencephalography, and single-photon emission computed tomography (50.0%, 61.1%, and 61.6%, respectively). Scalp video electroencephalography, magnetoencephalography, and single-photon emission computed tomography showed similar specificities of 77.7%, while fluorodeoxyglucose-positron emission tomography showed a specificity of 55.5%. Combined modalities were able to achieve the highest sensitivity of 83.3% when there were at least 2 concordant modalities and a specificity of 100% with various multiple combinations. Our study showed that lobar concordance from multiple modalities increases the sensitivity and specificity for a seizure-free outcome in magnetic resonance imaging-negative focal epilepsy patients who underwent resective surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.